1 hr. ago
Broncos coach Sean Payton wants to see what he can do to keep his team healthier.
Payton said at training camp on Monday that he's concerned about the number of soft-tissue injuries his team has suffered so far in camp.
"We've got to get a handle on some of the soft-tissues," Payton said, via the Denver Post. "We've had a couple either strains, hamstring or groins. We continue to fight through that."
Payton said he doesn't want to blame the heat but does want to look at how the team can make sure the players are adequately taken care of, and taking care of themselves, before and during practice.
"You always try to look at your pre-practice routine," Payton said. "Your hydration, obviously. And it's incumbent on the player. It's hard for anyone to know your soft tissue. I'm always looking at maybe what we did leading up to the period when a guy had a strain."
#soft #tissue #care
Payton said at training camp on Monday that he's concerned about the number of soft-tissue injuries his team has suffered so far in camp.
"We've got to get a handle on some of the soft-tissues," Payton said, via the Denver Post. "We've had a couple either strains, hamstring or groins. We continue to fight through that."
Payton said he doesn't want to blame the heat but does want to look at how the team can make sure the players are adequately taken care of, and taking care of themselves, before and during practice.
"You always try to look at your pre-practice routine," Payton said. "Your hydration, obviously. And it's incumbent on the player. It's hard for anyone to know your soft tissue. I'm always looking at maybe what we did leading up to the period when a guy had a strain."
#soft #tissue #care
8 hours ago
According to The Athletic's James Boyd, Indianapolis Colts wide receiver Alec Pierce had another PRP injection in his rehabbing left ankle, which underwent minor cleanup surgery earlier this offseason:
While the timing of the second injection is unclear following surgery, it wasn't publicly disclosed by the team. That being said, Boyd later noted that the second PRP injection wasn't considered a setback by a team source. However, there's still no clear timetable for his return to the football field.
For those not in the medical field, a PRP injection is a 'platelet-rich plasma' injection to help repair damaged tissues and ease joint pain as a form of medical treatment.
The last public update we had received was from Pierce himself, when in early June, he indicated to the local media that there was a four-to-six month recovery timeline from his minor ankle surgery in late March. However, the hope was that he'd realistically return by late team training camp.
For what it's worth, ESPN NFL Insider Adam Schefter said on 'The Pat McAfee Show' on Monday that the Colts maintain that Pierce will be ready for the regular season opener.
#surgery #minor
While the timing of the second injection is unclear following surgery, it wasn't publicly disclosed by the team. That being said, Boyd later noted that the second PRP injection wasn't considered a setback by a team source. However, there's still no clear timetable for his return to the football field.
For those not in the medical field, a PRP injection is a 'platelet-rich plasma' injection to help repair damaged tissues and ease joint pain as a form of medical treatment.
The last public update we had received was from Pierce himself, when in early June, he indicated to the local media that there was a four-to-six month recovery timeline from his minor ankle surgery in late March. However, the hope was that he'd realistically return by late team training camp.
For what it's worth, ESPN NFL Insider Adam Schefter said on 'The Pat McAfee Show' on Monday that the Colts maintain that Pierce will be ready for the regular season opener.
#surgery #minor
1 day ago
The Lions worked out free agent cornerback Trevon Diggs, according to the NFL's personnel notice.
Diggs, 27, became a free agent Jan. 20 when the Packers cut him after two games and 34 snaps. The Packers had claimed him off waivers from the Cowboys on Dec. 31.
Diggs led the league with 11 interceptions in 2021, but he has not been the same player since his knee problems began in 2023. He tore his ACL in September 2023 and underwent an additional surgery on his knee in December 2024.
In January 2025, Diggs underwent a chondral tissue and bone graft surgery on his left knee to repair persistent cartilage damage.
He has played only 22 games over the past three seasons.
#diggs #free #agent #lions
Diggs, 27, became a free agent Jan. 20 when the Packers cut him after two games and 34 snaps. The Packers had claimed him off waivers from the Cowboys on Dec. 31.
Diggs led the league with 11 interceptions in 2021, but he has not been the same player since his knee problems began in 2023. He tore his ACL in September 2023 and underwent an additional surgery on his knee in December 2024.
In January 2025, Diggs underwent a chondral tissue and bone graft surgery on his left knee to repair persistent cartilage damage.
He has played only 22 games over the past three seasons.
#diggs #free #agent #lions
3 days ago
ATLANTA (AP) — An Atlanta-area woman alleges that she was wrongly diagnosed with cancer and underwent an unneeded hysterectomy because of a labeling error.
Cassandra Barksdale and her attorneys filed a lawsuit Tuesday against Kaiser Permanente alleging the mix-up led to the surgery and months of physical and emotional pain.
According to the lawsuit, another patient's tissue sample was mistakenly labeled as belonging to Barksdale, who at age 43 then underwent a full hysterectomy on May 15, 2025, and was told she would get instructions about chemotherapy.
It's unclear how the mix-up occurred. In September, Barksdale was informed that a DNA ****** ysis found the tissue sample showing an aggressive form of endometrial uterine cancer belonged to a different patient and not to her, the lawsuit says.
"She came into Kaiser Permanente looking for answers, and she left with a diagnosis that did not belong to her. And every step that was taken after that was based off of misinformation," her attorney Shannan Young said.
#underwent #hysterectomy
Cassandra Barksdale and her attorneys filed a lawsuit Tuesday against Kaiser Permanente alleging the mix-up led to the surgery and months of physical and emotional pain.
According to the lawsuit, another patient's tissue sample was mistakenly labeled as belonging to Barksdale, who at age 43 then underwent a full hysterectomy on May 15, 2025, and was told she would get instructions about chemotherapy.
It's unclear how the mix-up occurred. In September, Barksdale was informed that a DNA ****** ysis found the tissue sample showing an aggressive form of endometrial uterine cancer belonged to a different patient and not to her, the lawsuit says.
"She came into Kaiser Permanente looking for answers, and she left with a diagnosis that did not belong to her. And every step that was taken after that was based off of misinformation," her attorney Shannan Young said.
#underwent #hysterectomy
3 days ago
Since rebuilding their entire training staff, the New Orleans Saints have seen a positive impact on their team. Even though there were some major injuries throughout last season- that's always going to happen in football- the pesky soft tissue issues that plagued the team in the past have not been as prevalent.
This season, the hope was that their injury luck would continue, and although things could be worse, after Week 1, there have already been some issues that affect the roster. So, let's look this week's injury update for the Saints.
By now everybody knows about this one, but it's important to still talk about. Bryan Bresee was set to be a major piece on the defensive line, and for his future career, it needed to be a big year from him. Instead, after suffering a knee injury, Bresee will be out for the entire season.
For the Saints' defensive line, it's going to be harder for the Saints to deal with this loss, and for Bresee, this puts extreme pressure on him next season. It's going to be a contract year, and if Bresee can't bounce back and show improvement, the Saints may not bring him back.
Before training camp, DT Christen Miller was dealing with some injury issues, but has been healthy since. He is an extremely important piece of the defensive line, just like Bresee was, but Miller's main spot will be at nose tackle. Miller should be the heir apparent to Davon Godchaux, and staying on the field could accelerate that.
#saints
This season, the hope was that their injury luck would continue, and although things could be worse, after Week 1, there have already been some issues that affect the roster. So, let's look this week's injury update for the Saints.
By now everybody knows about this one, but it's important to still talk about. Bryan Bresee was set to be a major piece on the defensive line, and for his future career, it needed to be a big year from him. Instead, after suffering a knee injury, Bresee will be out for the entire season.
For the Saints' defensive line, it's going to be harder for the Saints to deal with this loss, and for Bresee, this puts extreme pressure on him next season. It's going to be a contract year, and if Bresee can't bounce back and show improvement, the Saints may not bring him back.
Before training camp, DT Christen Miller was dealing with some injury issues, but has been healthy since. He is an extremely important piece of the defensive line, just like Bresee was, but Miller's main spot will be at nose tackle. Miller should be the heir apparent to Davon Godchaux, and staying on the field could accelerate that.
#saints
6 days ago
The Chicago Bears were back at Halas Hall for their sixth practice of training camp on Tuesday, where they conducted their second straight padded practice.
The Bears kicked things up a notch on Day 6, where they had several live periods. There was plenty of physicality and intensity on display, which even led to the first scuffle of training camp between two rookies. Overall, it was a win for the defense and the offense had its share of struggles. There was some good injury news as running back Kyle Monangai returned to team drills as he overcomes a soft tissue injury. There were also some notable developments in several position battles.
Let's recap Day 6 of Bears training camp:
Rough showing for offense: The Bears passing game continues to show promise heading into the season, and wide receiver Luther Burden III and tight end Colston Loveland "continued their strong camp today," per Bear Report. But, overall, it was a rough showing for the offense. According to Dan Wiederer, this looked like the "sloppiest offensive showing of camp to date. Easily." Wiederer noted that there were a number of struggles, including: "Pre-snap penalties. Misfired passes. Dropped **** . Rickety screen plays. QB1's feet getting tangled coming out from center." On top of that, quarterback Caleb Williams was intercepted by cornerback Tyrique Stevenson. It appeared to be a miscommunication between Williams and tight end Colston Loveland. Greg Braggs added that the "defense looks a step ahead" and the offense "has looked off more than the other practices." He noted it was timing and energy seemed low, especially with live periods. The offense also fell short during the two-minute drill, where quarterback Caleb Williams and Burden were unable to connect on fourth down in the end zone.
Heavy focus on the run game, 13 personnel: Tuesday's padded practice featured heavy focus on the run game and 13 personnel, both of which will be key to Ben Johnson's offense being successful. Before practice, defensive coordinator made it clear there would be a heavy focus on 13 personnel, and Courtney Cronin noted that it was "clear the emphasis is gonna be running out of 13." According to Bear Report, they "went more run heavy today, by design. The run game should be strong once again. Working a lot of run concepts with the 12 and 13 personnel." They also noted that Chicago was mixing in receivers when they went 13 personnel.
#personnel #practice #game #williams
The Bears kicked things up a notch on Day 6, where they had several live periods. There was plenty of physicality and intensity on display, which even led to the first scuffle of training camp between two rookies. Overall, it was a win for the defense and the offense had its share of struggles. There was some good injury news as running back Kyle Monangai returned to team drills as he overcomes a soft tissue injury. There were also some notable developments in several position battles.
Let's recap Day 6 of Bears training camp:
Rough showing for offense: The Bears passing game continues to show promise heading into the season, and wide receiver Luther Burden III and tight end Colston Loveland "continued their strong camp today," per Bear Report. But, overall, it was a rough showing for the offense. According to Dan Wiederer, this looked like the "sloppiest offensive showing of camp to date. Easily." Wiederer noted that there were a number of struggles, including: "Pre-snap penalties. Misfired passes. Dropped **** . Rickety screen plays. QB1's feet getting tangled coming out from center." On top of that, quarterback Caleb Williams was intercepted by cornerback Tyrique Stevenson. It appeared to be a miscommunication between Williams and tight end Colston Loveland. Greg Braggs added that the "defense looks a step ahead" and the offense "has looked off more than the other practices." He noted it was timing and energy seemed low, especially with live periods. The offense also fell short during the two-minute drill, where quarterback Caleb Williams and Burden were unable to connect on fourth down in the end zone.
Heavy focus on the run game, 13 personnel: Tuesday's padded practice featured heavy focus on the run game and 13 personnel, both of which will be key to Ben Johnson's offense being successful. Before practice, defensive coordinator made it clear there would be a heavy focus on 13 personnel, and Courtney Cronin noted that it was "clear the emphasis is gonna be running out of 13." According to Bear Report, they "went more run heavy today, by design. The run game should be strong once again. Working a lot of run concepts with the 12 and 13 personnel." They also noted that Chicago was mixing in receivers when they went 13 personnel.
#personnel #practice #game #williams
6 days ago
Carlos Alcaraz still isn't ready to return from his lingering wrist injury.
Alcaraz withdrew from the Cincinnati Open on Tuesday, ending hopes that he'd be ready to make his return to the sport after missing both the French Open and Wimbledon already this season. His status for the US Open later this month is still very much up in the air.
"We know Carlos is doing everything he can to get back to playing tournaments as soon as possible," Cincinnati Open tournament director Bob Moran said in a statement. "We wish him the best with his recovery and look forward to welcoming him back to Cincinnati in teh future."
Alcaraz has been dealing with tenosynovitis in his wrist, which is the inflammation of the connective tissue that protects tendons, per the Cleveland Clinic. That can make it painful and difficult to move joints.
As a result, Alcaraz has missed both Wimbledon and the French Open this season. Top-ranked Jannik Sinner won Wimbledon last month with Alcaraz sidelined. He hasn't played since initially suffering the injury back at the Barcelona Open in April.
#french
Alcaraz withdrew from the Cincinnati Open on Tuesday, ending hopes that he'd be ready to make his return to the sport after missing both the French Open and Wimbledon already this season. His status for the US Open later this month is still very much up in the air.
"We know Carlos is doing everything he can to get back to playing tournaments as soon as possible," Cincinnati Open tournament director Bob Moran said in a statement. "We wish him the best with his recovery and look forward to welcoming him back to Cincinnati in teh future."
Alcaraz has been dealing with tenosynovitis in his wrist, which is the inflammation of the connective tissue that protects tendons, per the Cleveland Clinic. That can make it painful and difficult to move joints.
As a result, Alcaraz has missed both Wimbledon and the French Open this season. Top-ranked Jannik Sinner won Wimbledon last month with Alcaraz sidelined. He hasn't played since initially suffering the injury back at the Barcelona Open in April.
#french
7 days ago
The possibility of Aaron Donald coming out of retirement to join the Los Angeles Rams is perhaps the biggest storyline around the NFL. Andrew Whitworth added fuel to the fire as he seems to expect Donald will be rejoining the Rams at some point.
Whether it's Sean McVay, Whitworth, Donald himself, no one is saying it's not going to happen. At this point, people are mostly and moreso saying that Donald is more likely to come back than not. That can change, and Donald may not come back, but it's being set up that he's expected to return. For now.
If that is truly announced, that will be major news. Until then, it's speculation, and it's still news as is.
Thank you for checking out Turf Show Times and have a great Tuesday! NFL season is getting closer.
"A lot of people think about the games and stuff, but it's really putting your body through the impacts and the down in and down out of running into other big, strong humans all the time," he said. "Your tissue doesn't just walk around ready for that. You've got to prepare, and so I think some of this was him, 'Hey, is the passion still there? Do I still have that ability to be sore as ******* and every day wanting to go chase it. And I think for him, that kind of meant for the last month, month and a half, really training like a football player and doing some of the drills, some of the things he used to do day in and day out and seeing where he's at physically. And that's some of the stuff we talked about. I asked him where he's at. Is he still training? Does he still think he wants to do it? I think there's still a definite curiosity to do it. I think he's super fired up about trying to see if it's there, but I think it takes time to find out, is the drive still there?"
#think #donald #whitworth #saying
Whether it's Sean McVay, Whitworth, Donald himself, no one is saying it's not going to happen. At this point, people are mostly and moreso saying that Donald is more likely to come back than not. That can change, and Donald may not come back, but it's being set up that he's expected to return. For now.
If that is truly announced, that will be major news. Until then, it's speculation, and it's still news as is.
Thank you for checking out Turf Show Times and have a great Tuesday! NFL season is getting closer.
"A lot of people think about the games and stuff, but it's really putting your body through the impacts and the down in and down out of running into other big, strong humans all the time," he said. "Your tissue doesn't just walk around ready for that. You've got to prepare, and so I think some of this was him, 'Hey, is the passion still there? Do I still have that ability to be sore as ******* and every day wanting to go chase it. And I think for him, that kind of meant for the last month, month and a half, really training like a football player and doing some of the drills, some of the things he used to do day in and day out and seeing where he's at physically. And that's some of the stuff we talked about. I asked him where he's at. Is he still training? Does he still think he wants to do it? I think there's still a definite curiosity to do it. I think he's super fired up about trying to see if it's there, but I think it takes time to find out, is the drive still there?"
#think #donald #whitworth #saying
7 days ago
Sean McVay informed reporters on Monday afternoon that fourth year tight end Davis Allen is dealing with a quad injury in training camp. McVay did not provide a concrete timeline other than the injury is going to require "some time".
In all likelihood, Davis Allen misses at least the next two weeks with it being a soft tissue injury and the Rams typically being conservative with their injuries in training camp.
Allen has steadily carved out a role in Sean McVay's offense over the past several seasons. Whether serving as a reliable blocker, contributing as a pass catcher, or filling in whenever injuries have arisen, he has become a dependable member of the Rams' tight end room. Any missed practice reps can slow momentum, particularly during training camp when timing and chemistry are being refined before the regular season.
Fortunately for Los Angeles, this is one position where the roster is built to withstand a temporary setback.
While any injury to a player is unfortunate, the Rams can afford an injury like this at the tight end position because of the impressive depth they have ******* embled. Veterans Tyler Higbee and Colby Parkinson remain the leaders of the group, while Terrance Ferguson adds another talented option capable of making plays in the passing game.
#allen #camp #davis
In all likelihood, Davis Allen misses at least the next two weeks with it being a soft tissue injury and the Rams typically being conservative with their injuries in training camp.
Allen has steadily carved out a role in Sean McVay's offense over the past several seasons. Whether serving as a reliable blocker, contributing as a pass catcher, or filling in whenever injuries have arisen, he has become a dependable member of the Rams' tight end room. Any missed practice reps can slow momentum, particularly during training camp when timing and chemistry are being refined before the regular season.
Fortunately for Los Angeles, this is one position where the roster is built to withstand a temporary setback.
While any injury to a player is unfortunate, the Rams can afford an injury like this at the tight end position because of the impressive depth they have ******* embled. Veterans Tyler Higbee and Colby Parkinson remain the leaders of the group, while Terrance Ferguson adds another talented option capable of making plays in the passing game.
#allen #camp #davis
7 days ago
The Los Angeles Rams have an abundance of depth at tight end, which is a good thing because one of their key players is a bit banged up. Sean McVay told reporters on Monday that Davis Allen has a quad injury and will be out for "some time." Because it's a soft tissue injury, the team isn't going to rush him back.
Allen is in his fourth season with the Rams after being a fifth-round pick in 2023 out of Clemson.
Colby Parkinson, Terrance Ferguson and Tyler Higbee are the primary contributors at tight end, with rookie Max Klare also in the mix. Klare figures to get more reps with Allen out, which will only benefit the rookie out of Ohio State.
Allen caught 24 passes for 208 yards and three touchdowns last season, playing significant snaps after the team shifted toward more 13 personnel packages.
This article originally appeared on Rams Wire: Rams TE Davis Allen out for 'some time' with quad injury
#quad
Allen is in his fourth season with the Rams after being a fifth-round pick in 2023 out of Clemson.
Colby Parkinson, Terrance Ferguson and Tyler Higbee are the primary contributors at tight end, with rookie Max Klare also in the mix. Klare figures to get more reps with Allen out, which will only benefit the rookie out of Ohio State.
Allen caught 24 passes for 208 yards and three touchdowns last season, playing significant snaps after the team shifted toward more 13 personnel packages.
This article originally appeared on Rams Wire: Rams TE Davis Allen out for 'some time' with quad injury
#quad
7 days ago
The Los Angeles Rams continue to steadily ramp things up before Week 1 of the regular season, putting on the pads at practice this week. Monday's session marked the fourth straight practice, wrapping up the second block of camp; Sean McVay structured the schedule to feature three blocks of practice, with one day off in between.
Matthew Stafford was back on the field Monday after sitting out Friday and Sunday's sessions, taking over first-team reps at quarterback after Stetson Bennett handled those duties in his absence. Bennett still had a strong day with the second-team offense, continuing to put his stamp on the QB2 battle with Ty Simpson.
Below are updates from practice, including a couple pieces of injury news.
Myles Garrett missed his fourth straight practice with lower body soreness, but he's expected to return on Wednesday.
Davis Allen is dealing with a quad injury and will be out for "some time." McVay said the Rams won't rush him back because it's a soft-tissue injury.
#injury #week
Matthew Stafford was back on the field Monday after sitting out Friday and Sunday's sessions, taking over first-team reps at quarterback after Stetson Bennett handled those duties in his absence. Bennett still had a strong day with the second-team offense, continuing to put his stamp on the QB2 battle with Ty Simpson.
Below are updates from practice, including a couple pieces of injury news.
Myles Garrett missed his fourth straight practice with lower body soreness, but he's expected to return on Wednesday.
Davis Allen is dealing with a quad injury and will be out for "some time." McVay said the Rams won't rush him back because it's a soft-tissue injury.
#injury #week
10 days ago
Interested in Castle Biosciences, Inc.? Here are five stocks we like better.
Castle Biosciences reported strong Q2 growth, with revenue rising 20% year over year to $103.5 million. The company raised its 2026 revenue outlook to $365 million–$375 million, up from $345 million–$355 million previously.
TissueCypher was the primary growth driver, generating 14,988 reports, up 63% year over year. Castle now expects TissueCypher report volume to increase approximately 50%–52% in 2026, while AdvanceAD-Tx exceeded 1,000 orders in the quarter.
Despite higher revenue, gross margins declined and Castle posted a $2.1 million net loss, although adjusted EBITDA rose to $12.4 million. Management expects positive adjusted EBITDA in Q3, Q4 and for full-year 2026, supported by $266.8 million in cash and investments at quarter-end.
Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported results. The company raised its full-year revenue outlook to $365 million to $375 million, from a previous range of $345 million to $355 million.
#year #quarter
Castle Biosciences reported strong Q2 growth, with revenue rising 20% year over year to $103.5 million. The company raised its 2026 revenue outlook to $365 million–$375 million, up from $345 million–$355 million previously.
TissueCypher was the primary growth driver, generating 14,988 reports, up 63% year over year. Castle now expects TissueCypher report volume to increase approximately 50%–52% in 2026, while AdvanceAD-Tx exceeded 1,000 orders in the quarter.
Despite higher revenue, gross margins declined and Castle posted a $2.1 million net loss, although adjusted EBITDA rose to $12.4 million. Management expects positive adjusted EBITDA in Q3, Q4 and for full-year 2026, supported by $266.8 million in cash and investments at quarter-end.
Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported results. The company raised its full-year revenue outlook to $365 million to $375 million, from a previous range of $345 million to $355 million.
#year #quarter
13 days ago
It's official; training camp is here. The Washington Commanders will unofficially kick off preparations for the 2026 season on Wednesday, the first day of training camp. Rookies reported to Ashburn last Friday, while the rest of the team reported on Tuesday.
Before players hit the practice field on Wednesday, general manager Adam Peters and head coach Dan Quinn met with the media to preview camp and discuss other topics surrounding the team. Last week, the Commanders made some moves, placing cornerback Trey Amos, edge rusher Dorance Armstrong and defensive end Deatrich Wise Jr. on the Active/Physically Unable to Perform (PUP) list.
Peters was asked about Amos, who suffered a fractured fibula in Week 10 last season.
"Yeah, I think with Trey, he's doing really well," Peters said. "I think the first thing I'll say is he's been outstanding in his rehab and really, you know, taken all the things that the medical team has asked him to do and done really well. With him, just had a little soft tissue soreness in the offseason, so we wanted to just take it slow. So, he's actually doing really well right now. Just had a report on him earlier. He should be back soon as well. Just wanted to be overly cautious there, but he's doing great. He'll be back pretty soon."
https://t.co/K4ccYvBxaX
#really #camp
Before players hit the practice field on Wednesday, general manager Adam Peters and head coach Dan Quinn met with the media to preview camp and discuss other topics surrounding the team. Last week, the Commanders made some moves, placing cornerback Trey Amos, edge rusher Dorance Armstrong and defensive end Deatrich Wise Jr. on the Active/Physically Unable to Perform (PUP) list.
Peters was asked about Amos, who suffered a fractured fibula in Week 10 last season.
"Yeah, I think with Trey, he's doing really well," Peters said. "I think the first thing I'll say is he's been outstanding in his rehab and really, you know, taken all the things that the medical team has asked him to do and done really well. With him, just had a little soft tissue soreness in the offseason, so we wanted to just take it slow. So, he's actually doing really well right now. Just had a report on him earlier. He should be back soon as well. Just wanted to be overly cautious there, but he's doing great. He'll be back pretty soon."
https://t.co/K4ccYvBxaX
#really #camp
14 days ago
When it comes to Chicago Bears cornerback Kyler Gordon, the one word that encapsulates his current injury situation is "frustration."
Gordon, a former second-round pick, was hampered by soft tissue injuries last season, playing in just three regular-season games with two stints on injured reserve. After playing in two postseason games, the arrow was pointed up for Gordon, who's elevated the defense when he's on the field.
But Gordon suffered yet another soft tissue injury -- a calf injury, as confirmed by general manager Ryan Poles -- that held him out of the offseason program and has him on the physically unable to perform (PUP) list to start training camp. There's also no current timetable for his return.
"Obviously, he's frustrated," Poles said Tuesday. "We're frustrated. Everybody here is putting their time and effort into getting him back."
Head coach Ben Johnson hasn't been shy when it comes to voicing his frustration with Gordon, making it clear that his lack of availability has been a problem. On report day, Johnson had a message to Gordon as he starts the summer injured.
#soft #season
Gordon, a former second-round pick, was hampered by soft tissue injuries last season, playing in just three regular-season games with two stints on injured reserve. After playing in two postseason games, the arrow was pointed up for Gordon, who's elevated the defense when he's on the field.
But Gordon suffered yet another soft tissue injury -- a calf injury, as confirmed by general manager Ryan Poles -- that held him out of the offseason program and has him on the physically unable to perform (PUP) list to start training camp. There's also no current timetable for his return.
"Obviously, he's frustrated," Poles said Tuesday. "We're frustrated. Everybody here is putting their time and effort into getting him back."
Head coach Ben Johnson hasn't been shy when it comes to voicing his frustration with Gordon, making it clear that his lack of availability has been a problem. On report day, Johnson had a message to Gordon as he starts the summer injured.
#soft #season
18 days ago
Vince Goodwill: Jalen Brunson is going to come get all of his money. Every bit that he.. I won't say he sacrificed. He signed a year early, right? He signed a year early. He could have signed for a hundred million dollars more by signing later. Every dollar of that what 280 or 300 million that he's supposed to get next summer, he's going to get all of that.
YouTube
Vince Goodwill: Jalen Brunson is going to come get all of his money. Every bit that he.. I won't say he sacrificed. He signed a year early, right? He signed a year early. He could have signed for a hundred million dollars more by signing later. Every dollar of that what 280 or 300 million that he's supposed to get next summer, he's going to get all of that. — 7/24/2026 YouTube
NBA 2K: Ball Over Everything 100%. Pre-order NBA 2K27 now! Andre Drummond: How’s Jalen Brunson not the cover? — 7/23/2026 x.com
Following the Knicks’ championship win, in which Jalen Brunson was named NBA Finals MVP and scored 45 points in the close-out game, he had surgery to repair a tendon in his left wrist. Fans — including this writer — were surprised that Brunson turned in a Michael Jordan-esque performance in the Finals with a **** wrist, and he sported a cast to the interview. “I was more in pain when I wasn’t in the game versus when we were actually playing. I feel like the adrenaline took over. But yeah, it was definitely an obstacle, but we found a way through,” he describes, adding, “Because it’s my tendon and my structure, my wrist is fine. There was soft tissue that was holding my tendon and it kept flipping and snapping over the bone every time I shot, every time I flicked my wrist, and so clearly it was causing pain, causing friction… I’ll be in this [cast] for about another six weeks, and then from that point on, it’s just my rehab after that. But I should be good.” — 7/22/2026 Variety.com
#year #early
YouTube
Vince Goodwill: Jalen Brunson is going to come get all of his money. Every bit that he.. I won't say he sacrificed. He signed a year early, right? He signed a year early. He could have signed for a hundred million dollars more by signing later. Every dollar of that what 280 or 300 million that he's supposed to get next summer, he's going to get all of that. — 7/24/2026 YouTube
NBA 2K: Ball Over Everything 100%. Pre-order NBA 2K27 now! Andre Drummond: How’s Jalen Brunson not the cover? — 7/23/2026 x.com
Following the Knicks’ championship win, in which Jalen Brunson was named NBA Finals MVP and scored 45 points in the close-out game, he had surgery to repair a tendon in his left wrist. Fans — including this writer — were surprised that Brunson turned in a Michael Jordan-esque performance in the Finals with a **** wrist, and he sported a cast to the interview. “I was more in pain when I wasn’t in the game versus when we were actually playing. I feel like the adrenaline took over. But yeah, it was definitely an obstacle, but we found a way through,” he describes, adding, “Because it’s my tendon and my structure, my wrist is fine. There was soft tissue that was holding my tendon and it kept flipping and snapping over the bone every time I shot, every time I flicked my wrist, and so clearly it was causing pain, causing friction… I’ll be in this [cast] for about another six weeks, and then from that point on, it’s just my rehab after that. But I should be good.” — 7/22/2026 Variety.com
#year #early
18 days ago
Grassroots sports clubs across Shropshire say they are struggling to keep their pitches alive because of the hot, dry weather.
Telford Hornets Rugby Club are one of many who said the pitches they play on are dying because spending to irrigate would cost them thousands of pounds, money which they do not have.
Since 15 June, most of England has recorded less than 10mm of rain, which has meant many clubs are praying for a sustained downpour.
The club's chairman, Neil Thomas, said they have had to learn strategies to keep their pitches in as good condition as possible, so they can continue playing on them.
As many sport teams return from their off-season, players are faced with the prospect of playing on hardened pitches, which physiotherapists say increase the chances of soft tissue injuries.
#many #keep #telford #Rugby
Telford Hornets Rugby Club are one of many who said the pitches they play on are dying because spending to irrigate would cost them thousands of pounds, money which they do not have.
Since 15 June, most of England has recorded less than 10mm of rain, which has meant many clubs are praying for a sustained downpour.
The club's chairman, Neil Thomas, said they have had to learn strategies to keep their pitches in as good condition as possible, so they can continue playing on them.
As many sport teams return from their off-season, players are faced with the prospect of playing on hardened pitches, which physiotherapists say increase the chances of soft tissue injuries.
#many #keep #telford #Rugby
19 days ago
Fred Alger Management, an investment management company, released its "Alger Weatherbie Specialized Growth Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery in Q2 2026, with the S&P 500 Index gaining 15.2%, marking its best quarter since 2020. A ceasefire between the United States and Iran and accelerated investment in artificial intelligence (AI) regained market optimism in the quarter, leading the Information Technology and Industrials sectors upward, and Energy and Utilities lagged because of falling oil and gas prices. In June, the Federal Reserve maintained steady interest rates, but the meeting had a hawkish tone. As AI transitions into its agentic phase, opportunities are identified within sectors adopting the technology. The Weatherbie Specialized Growth Fund's Class A shares outperformed the Russell 2500 Growth Index in the quarter. The Industrials and Information Technology sectors contributed to the relative performance, whereas Financials and Consumer Discretionary sectors detracted. In addition, please check the Fund's top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, Alger Weatherbie Specialized Growth Fund highlighted Artivion, Inc. (NYSE:AORT). Artivion, Inc. (NYSE:AORT) is a global manufacturer and distributor of medical devices and implantable human tissues. On July 20, 2026, Artivion, Inc. (NYSE:AORT) closed at $25.37 per share. One-month return of Artivion, Inc. (NYSE:AORT) was 22.68%, and its shares lost 16.55% over the past 52 weeks. Artivion, Inc. (NYSE:AORT) has a market capitalization of $1.23 billion.
Alger Weatherbie Specialized Growth Fund stated the following regarding Artivion, Inc. (NYSE:AORT) in its Q2 2026 investor update:
"Artivion, Inc. (NYSE:AORT) manufactures, processes, and distributes medical devices and implantable human tissues used in cardiac and vascular surgical procedures, with a focus on treating patients with aortic disease. The company's portfolio includes established products as well as newer technologies designed to improve outcomes in complex cardiovascular procedures. During the quarter, shares detracted from performance after the company reported in-line first-quarter results but modestly lowered its full-year outlook, primarily due to slower-than-expected starter set sales for AMDS, its key new product cycle."
Artivion, Inc. (NYSE:AORT) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 28 hedge fund portfolios held Artivion, Inc. (NYSE:AORT) at the end of the first quarter, up from 25 in the previous quarter. Artivion, Inc. (NYSE:AORT) delivered total revenue of $116.3 million in Q1 2026, an increase of 12% on a non-GAAP constant currency basis. While we acknowledge the potential of Artivion, Inc. (NYSE:AORT) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If y
In its Q2 2026 investor letter, Alger Weatherbie Specialized Growth Fund highlighted Artivion, Inc. (NYSE:AORT). Artivion, Inc. (NYSE:AORT) is a global manufacturer and distributor of medical devices and implantable human tissues. On July 20, 2026, Artivion, Inc. (NYSE:AORT) closed at $25.37 per share. One-month return of Artivion, Inc. (NYSE:AORT) was 22.68%, and its shares lost 16.55% over the past 52 weeks. Artivion, Inc. (NYSE:AORT) has a market capitalization of $1.23 billion.
Alger Weatherbie Specialized Growth Fund stated the following regarding Artivion, Inc. (NYSE:AORT) in its Q2 2026 investor update:
"Artivion, Inc. (NYSE:AORT) manufactures, processes, and distributes medical devices and implantable human tissues used in cardiac and vascular surgical procedures, with a focus on treating patients with aortic disease. The company's portfolio includes established products as well as newer technologies designed to improve outcomes in complex cardiovascular procedures. During the quarter, shares detracted from performance after the company reported in-line first-quarter results but modestly lowered its full-year outlook, primarily due to slower-than-expected starter set sales for AMDS, its key new product cycle."
Artivion, Inc. (NYSE:AORT) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 28 hedge fund portfolios held Artivion, Inc. (NYSE:AORT) at the end of the first quarter, up from 25 in the previous quarter. Artivion, Inc. (NYSE:AORT) delivered total revenue of $116.3 million in Q1 2026, an increase of 12% on a non-GAAP constant currency basis. While we acknowledge the potential of Artivion, Inc. (NYSE:AORT) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If y
20 days ago
Ricki Lake is celebrating the "leap of faith" she took two years ago when she underwent a facelift after losing weight that left her with loose skin.
The 57-year-old shared before-and-after photos of the procedure on Instagram on July 18, giving fans a look at her transformation.
"Happy 2 year anniversary to me. Yes, 2 years ago today, I had a face lift. Specifically, for those wondering, I had a deep plane lower face and neck lift along with a mild co2 laser," she captioned the carousel.
According to the American Society of Plastic Surgeons, a deep-plane lower face and neck lift repositions deeper facial tissues to restore a more youthful jawline and neck. CO₂ laser resurfacing removes damaged outer layers of skin to improve wrinkles, texture, and sun damage.
Lake thanked her "talented and kind" plastic surgeon, Dr. Allen Foulad, saying he delivered results that are "remarkable, natural, and long-lasting."
#lift #years
The 57-year-old shared before-and-after photos of the procedure on Instagram on July 18, giving fans a look at her transformation.
"Happy 2 year anniversary to me. Yes, 2 years ago today, I had a face lift. Specifically, for those wondering, I had a deep plane lower face and neck lift along with a mild co2 laser," she captioned the carousel.
According to the American Society of Plastic Surgeons, a deep-plane lower face and neck lift repositions deeper facial tissues to restore a more youthful jawline and neck. CO₂ laser resurfacing removes damaged outer layers of skin to improve wrinkles, texture, and sun damage.
Lake thanked her "talented and kind" plastic surgeon, Dr. Allen Foulad, saying he delivered results that are "remarkable, natural, and long-lasting."
#lift #years
25 days ago
The milestone payment strengthens VivoSim's cash position while management projects significant revenue growth driven by expanding demand for its human-based preclinical testing platform.
VivoSim (NASDAQ:VIVS) received a $5 million milestone payment from Eli Lilly tied to the advancement of a previously sold drug candidate into Phase 2 studies.
The company expects more than 500% revenue growth in fiscal 2027, reflecting increasing adoption of its NAM contract research services.
VivoSim remains eligible for up to $45 million in additional milestone payments if future regulatory and commercial milestones are achieved.
Management says demand is being supported by growing pharmaceutical interest in New Approach Methodologies (NAMs) and AI-enabled human tissue models.
VivoSim (NASDAQ:VIVS) received a $5 million milestone payment from Eli Lilly tied to the advancement of a previously sold drug candidate into Phase 2 studies.
The company expects more than 500% revenue growth in fiscal 2027, reflecting increasing adoption of its NAM contract research services.
VivoSim remains eligible for up to $45 million in additional milestone payments if future regulatory and commercial milestones are achieved.
Management says demand is being supported by growing pharmaceutical interest in New Approach Methodologies (NAMs) and AI-enabled human tissue models.
25 days ago
A less invasive therapy for prostate cancer is just as effective as surgery or radiotherapy but with a lower risk of side effects, a major study suggests.
The treatment, named focal therapy, uses high-intensity ultrasound or freezing cryotherapy to destroy cancerous tissue.
A 10-year NHS study led by Imperial College London followed nearly 3,500 men who received the therapy, providing long-term data that medical regulators had previously said was missing.
Researchers say the results are "excellent" and they are likely to add to pressure for focal therapy to be made more widely available.
Nearly all the men had intermediate or high-risk prostate cancer - but 10 years after treatment only two had died from the disease.
The treatment, named focal therapy, uses high-intensity ultrasound or freezing cryotherapy to destroy cancerous tissue.
A 10-year NHS study led by Imperial College London followed nearly 3,500 men who received the therapy, providing long-term data that medical regulators had previously said was missing.
Researchers say the results are "excellent" and they are likely to add to pressure for focal therapy to be made more widely available.
Nearly all the men had intermediate or high-risk prostate cancer - but 10 years after treatment only two had died from the disease.
29 days ago
The aortic tear that likely caused the sudden death of Sen. Lindsey Graham is a medical emergency that can rapidly kill.
The aorta is our largest artery, like a highway that arches up from the heart and then curves back down through the abdomen — carrying oxygen-rich blood to the rest of the body as other arteries branch off from it.
What doctors call an aortic dissection happens when a tear in its inner lining lets blood rapidly leak between its other layers, according to the American Heart ******* ociation. That reduces blood flow to vital organs, and sometimes can lead to a rupture that pours blood into surrounding tissues. It often can be caused by an aortic aneurysm, a weakened spot on the artery that can bulge like a balloon.
Risk factors include high blood pressure, high cholesterol that in turn stiffens arteries — called atherosclerosis — and smoking. It's more common in older people but also can be caused by certain genetic conditions in younger people.
A preliminary medical examiner's report shared by Graham's office said the aortic dissection was related to artery hardening.
The aorta is our largest artery, like a highway that arches up from the heart and then curves back down through the abdomen — carrying oxygen-rich blood to the rest of the body as other arteries branch off from it.
What doctors call an aortic dissection happens when a tear in its inner lining lets blood rapidly leak between its other layers, according to the American Heart ******* ociation. That reduces blood flow to vital organs, and sometimes can lead to a rupture that pours blood into surrounding tissues. It often can be caused by an aortic aneurysm, a weakened spot on the artery that can bulge like a balloon.
Risk factors include high blood pressure, high cholesterol that in turn stiffens arteries — called atherosclerosis — and smoking. It's more common in older people but also can be caused by certain genetic conditions in younger people.
A preliminary medical examiner's report shared by Graham's office said the aortic dissection was related to artery hardening.
1 month ago
Memphis, Tennessee-based International Paper Company (IP) produces and sells renewable fiber-based packaging and pulp products. Valued at $20.4 billion by market cap, the company offers linerboard, medium, whitetop, recycled linerboard, recycled medium and saturating kraft, and pulp for a range of applications, such as diapers, towel and tissue products, feminine care, and other personal care products. The global leader in sustainable packaging solutionsis expected to announce its fiscal second-quarter earnings for 2026 before the market opens on Thursday, Jul. 30.
Ahead of the event, ***** ysts expect IP to report a loss of $0.01 per share on a diluted basis, down 105% from profit of $0.20 per share in the year-ago quarter. The company missed the consensus estimates in each of the last four quarters.
Nasdaq Futures Plunge as Samsung Sparks Chip Selloff
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
The Nasdaq-100 Could Be Forming a Textbook Diamond Top. Here's What to Watch on the QQQ Chart Now.
Ahead of the event, ***** ysts expect IP to report a loss of $0.01 per share on a diluted basis, down 105% from profit of $0.20 per share in the year-ago quarter. The company missed the consensus estimates in each of the last four quarters.
Nasdaq Futures Plunge as Samsung Sparks Chip Selloff
AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
The Nasdaq-100 Could Be Forming a Textbook Diamond Top. Here's What to Watch on the QQQ Chart Now.
1 month ago
Dallas Cowboys football player Marshawn Kneeland was suffering from stage 1 chronic traumatic encephalopathy (CTE) when he died by suicide last year, scientists said.
Researchers at Boston University's CTE Center made the diagnosis through a postmortem brain tissue ***** ysis of the defensive lineman, who died aged 24.
"Unfortunately, I was not surprised to find CTE in the brain of Mr Kneeland, because we have found this progressive brain disease in nearly half of the athletes we've studied who have died before the age of 30," said the centre's director, Dr Ann McKee.
Stage 1 is the mildest of CTE's four stages, where headaches and loss of attention or concentration are common symptoms.
In a statement, Kneeland's family said the diagnosis provided "important context" about some of the struggles he was facing.
Researchers at Boston University's CTE Center made the diagnosis through a postmortem brain tissue ***** ysis of the defensive lineman, who died aged 24.
"Unfortunately, I was not surprised to find CTE in the brain of Mr Kneeland, because we have found this progressive brain disease in nearly half of the athletes we've studied who have died before the age of 30," said the centre's director, Dr Ann McKee.
Stage 1 is the mildest of CTE's four stages, where headaches and loss of attention or concentration are common symptoms.
In a statement, Kneeland's family said the diagnosis provided "important context" about some of the struggles he was facing.
1 month ago
AUSTIN, Texas (AP) — Former Dallas Cowboys defensive end Marshawn Kneeland, who died by suicide in November 2025 after a high-speed chase with police, had early stage chronic traumatic encephalopathy, a brain abnormality linked to repeated concussions, his family announced Tuesday.
The Boston University CTE Center, which investigates the long-term consequences of repetitive brain trauma in athletes and others, ****** yzed Kneeland's brain tissue after his death. Researchers determined Kneeland, who was 24, was in stage one of four of CTE.
___
EDITOR’S NOTE — This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is also an online chat at 988lifeline.org
___
The Boston University CTE Center, which investigates the long-term consequences of repetitive brain trauma in athletes and others, ****** yzed Kneeland's brain tissue after his death. Researchers determined Kneeland, who was 24, was in stage one of four of CTE.
___
EDITOR’S NOTE — This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988. There is also an online chat at 988lifeline.org
___
1 month ago
The 2025 NFL season didn't go the way that former Washington Huskies star defensive back hoped it would with the Chicago Bears.
Even though his team was within striking distance of making the NFC Championship game in its first season under head coach Ben Johnson, the former second-round pick in the 2022 NFL draft was barely on the field. When including the playoffs, Gordon was limited to just five games while dealing with calf, groin, and hamstring injuries that forced him onto injured reserve two separate times during the year.
Now, heading into the first season of a three-year, $40 million contract extension he signed in April 2025, Johnson is hoping Gordon will be more available this fall, after he missed most of official team activities (OTAs) with a soft tissue injury.
“We spoke last year, and neither one of us were really happy with how it went, just from a perspective of being available to get to know each other," Johnson said. "I think he only played in three games when I look back at it. So this spring was going to be a springboard for us to get going in the right direction, and we're still working through that."
"We're still trying to get that availability piece going. We know he is a good player when he is out there, but trust level's a huge thing for this team, for this coaching staff, for the locker room. You can only develop that trust by being available.”
Even though his team was within striking distance of making the NFC Championship game in its first season under head coach Ben Johnson, the former second-round pick in the 2022 NFL draft was barely on the field. When including the playoffs, Gordon was limited to just five games while dealing with calf, groin, and hamstring injuries that forced him onto injured reserve two separate times during the year.
Now, heading into the first season of a three-year, $40 million contract extension he signed in April 2025, Johnson is hoping Gordon will be more available this fall, after he missed most of official team activities (OTAs) with a soft tissue injury.
“We spoke last year, and neither one of us were really happy with how it went, just from a perspective of being available to get to know each other," Johnson said. "I think he only played in three games when I look back at it. So this spring was going to be a springboard for us to get going in the right direction, and we're still working through that."
"We're still trying to get that availability piece going. We know he is a good player when he is out there, but trust level's a huge thing for this team, for this coaching staff, for the locker room. You can only develop that trust by being available.”
1 month ago
Johnson & Johnson (NYSE:JNJ) is one of billionaire Cliff Asness' top 10 healthcare stock picks. On June 25, Johnson & Johnson (NYSE:JNJ) announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe. That means the platform is now commercially available to electrophysiologists across the EMEA region for the treatment of cardiac arrhythmias, including atrial fibrillation.
Copyright: moovstock / 123RF Stock Photo
The company said that the platform is the first of its kind to combine two distinct energy sources in a single catheter-based solution. It combines radiofrequency (RF) and pulsed field (PF) energy to allow physicians to switch between the two during the same procedure without having to change equipment. This is clinically significant because RF and PF ablation each have different tissue effects and safety profiles, said Nicolas Derval, M.D., a consultant for Johnson & Johnson based in Bordeaux, France. Derval added that the ability to use both gives doctors more flexibility to tailor treatment to individual patient anatomy and disease patterns.
Johnson & Johnson explained that the platform consists of the DE STSF Catheter, which is an irrigated, contact-force sensing catheter that physically delivers energy to heart tissue. The other half consists of the TRUPULSE Generator, which controls and powers the delivery of both RF and PF energy. The company said the system is fully integrated with its CARTO 3 System, which is an electro-anatomical mapping platform. This combination enables real-time 3D visualization, contact-force feedback, and index-guided ablation during live procedures.
Johnson & Johnson (NYSE:JNJ) is a healthcare conglomerate. It operates through two segments: Innovative Medicine, which develops and markets prescription drugs in oncology, immunology, neuroscience, and infectious disease, and MedTech, which manufactures medical devices for surgery, orthopedics, and interventional solutions.
Copyright: moovstock / 123RF Stock Photo
The company said that the platform is the first of its kind to combine two distinct energy sources in a single catheter-based solution. It combines radiofrequency (RF) and pulsed field (PF) energy to allow physicians to switch between the two during the same procedure without having to change equipment. This is clinically significant because RF and PF ablation each have different tissue effects and safety profiles, said Nicolas Derval, M.D., a consultant for Johnson & Johnson based in Bordeaux, France. Derval added that the ability to use both gives doctors more flexibility to tailor treatment to individual patient anatomy and disease patterns.
Johnson & Johnson explained that the platform consists of the DE STSF Catheter, which is an irrigated, contact-force sensing catheter that physically delivers energy to heart tissue. The other half consists of the TRUPULSE Generator, which controls and powers the delivery of both RF and PF energy. The company said the system is fully integrated with its CARTO 3 System, which is an electro-anatomical mapping platform. This combination enables real-time 3D visualization, contact-force feedback, and index-guided ablation during live procedures.
Johnson & Johnson (NYSE:JNJ) is a healthcare conglomerate. It operates through two segments: Innovative Medicine, which develops and markets prescription drugs in oncology, immunology, neuroscience, and infectious disease, and MedTech, which manufactures medical devices for surgery, orthopedics, and interventional solutions.
1 month ago
Three Indiana Fever stars will be starters in the 2026 WNBA All-Star Game: Caitlin Clark, Aliyah Boston and Kelsey Mitchell.
They’ll be joined by the Las Vegas Aces’ A’ja Wilson, the Dallas Wings’ Paige Bueckers and Jessica Shepard, the Minnesota Lynx’s Natasha Howard and Olivia Miles, the Golden State Valkyries’ Gabby Williams and the New York Liberty’s Breanna Stewart.
Boston and Clark were the most popular among fans through the second returns of voting this year. They were each No. 1 overall picks and have been unequivocally essential to the Indiana Fever’s bloom. Boston is now a four-time All-Star, and Clark is a three-time All-Star. Boston is averaging a career-high 17 points per game. The versatile center’s stretched her game, becoming a threat from beyond the arc. She’s already netted 20 triples — three more than she combined to make her first three seasons in the league — plus, she’s shooting a personal-best 85.4% from the charity stripe.
Clark, meanwhile, has played 17 of Indiana’s 19 games, mostly bouncing back after missing the majority of the 2025 campaign with a variety of soft-tissue injuries. Clark is tied for third in the W with 21.2 points per game. Over her past eight games, she’s shooting 48.8% from the field, making at least a trio of 3-pointers five times in that span.
This year's WNBA All-Star Game will be played on July 25 at Chicago’s United Center.
They’ll be joined by the Las Vegas Aces’ A’ja Wilson, the Dallas Wings’ Paige Bueckers and Jessica Shepard, the Minnesota Lynx’s Natasha Howard and Olivia Miles, the Golden State Valkyries’ Gabby Williams and the New York Liberty’s Breanna Stewart.
Boston and Clark were the most popular among fans through the second returns of voting this year. They were each No. 1 overall picks and have been unequivocally essential to the Indiana Fever’s bloom. Boston is now a four-time All-Star, and Clark is a three-time All-Star. Boston is averaging a career-high 17 points per game. The versatile center’s stretched her game, becoming a threat from beyond the arc. She’s already netted 20 triples — three more than she combined to make her first three seasons in the league — plus, she’s shooting a personal-best 85.4% from the charity stripe.
Clark, meanwhile, has played 17 of Indiana’s 19 games, mostly bouncing back after missing the majority of the 2025 campaign with a variety of soft-tissue injuries. Clark is tied for third in the W with 21.2 points per game. Over her past eight games, she’s shooting 48.8% from the field, making at least a trio of 3-pointers five times in that span.
This year's WNBA All-Star Game will be played on July 25 at Chicago’s United Center.
1 month ago
A self-exiled billionaire Chinese business tycoon once believed to be among China's wealthiest men was sentenced Monday to 30 years in a US prison for a massive financial fraud that a federal judge said cost over 1,000 people worldwide hundreds of millions of dollars.
Guo Wengui, who fled China a decade ago and reinvented himself as a US -based Communist Party critic, was sentenced in a Manhattan courtroom packed with his supporters by Judge ******* isa Torres. She said he "preyed on those seeking to bring Democracy to China," taking their money so he could live lavishly.
Before he was sentenced, Guo protested his treatment in jail, saying he was taken to the hospital early Monday. He disputed a prosecutor's portrayal of him as a malinger faking illness, saying he repeatedly vomited as he was returned to jail before being brought to court.
"When I came here, I said: 'I have a tummy ache, I need to go to the bathroom, I don't feel well,'" Guo said through an interpreter of his courthouse arrival. Later, Guo wiped his mouth repeatedly with a tissue.
He only briefly addressed the criminal case, defending his intentions by saying in reference to the Chinese Communist Party: "The reason I came to the US was to destroy the CCP."
Guo Wengui, who fled China a decade ago and reinvented himself as a US -based Communist Party critic, was sentenced in a Manhattan courtroom packed with his supporters by Judge ******* isa Torres. She said he "preyed on those seeking to bring Democracy to China," taking their money so he could live lavishly.
Before he was sentenced, Guo protested his treatment in jail, saying he was taken to the hospital early Monday. He disputed a prosecutor's portrayal of him as a malinger faking illness, saying he repeatedly vomited as he was returned to jail before being brought to court.
"When I came here, I said: 'I have a tummy ache, I need to go to the bathroom, I don't feel well,'" Guo said through an interpreter of his courthouse arrival. Later, Guo wiped his mouth repeatedly with a tissue.
He only briefly addressed the criminal case, defending his intentions by saying in reference to the Chinese Communist Party: "The reason I came to the US was to destroy the CCP."
2 months ago
Grow Funds, an investment Advisor, released its Q1 2026 investor letter for "GROW Small Cap Equity Long/Short Fund". A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index's –2.80%, HFRI Equity Hedge Index's -0.24%, and the HFRI Fundamental Growth Index's 0.47% returns. Long positions and hedges, and short positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, please check the Strategy's top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Grow Funds highlighted Profound Medical Corp. (NASDAQ:PROF). Profound Medical Corp. (NASDAQ:PROF) is a Canada based commercial-stage medical device company that focuses on developing AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. On June 18, 2026, Profound Medical Corp. (NASDAQ:PROF) closed at $6.87 per share. One-month return of Profound Medical Corp. (NASDAQ:PROF) was 0.51%, and its shares gained 8.11% over the past 52 weeks. Profound Medical Corp. (NASDAQ:PROF) has a market capitalization of $248.09 million.
Grow Funds stated the following regarding Profound Medical Corp. (NASDAQ:PROF) in its Q1 2026 investor letter:
"Profound Medical Corp. (NASDAQ:PROF) is a commercial-stage medical device company advancing incision-free, MRI-guided, and robotically-driven technologies to treat prostate cancer and benign prostatic hyperplasia (BPH). Their lead technology, TULSA-PRO®, utilizes real-time MRI and thermal ultrasound to precisely ablate prostate tissue while preserving surrounding structures, aiming to minimize side effects like incontinence and impotence. Profound currently has 78 systems at marque hospitals, with a pipeline of over 110 systems. Reimbursement to the hospital is currently higher than competitive procedures. In addition, recent results from the Captain Trial demonstrate better outcomes than radical prostatectomy which is done primarily using the DaVinci robotic surgical system developed by Intuitive Surgical. Cook Medical and Siemens recently introduced their new iMRI suite, on which TULSA-PRO procedures can be performed."
Profound Medical Corp. (NASDAQ:PROF) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 6 hedge fund portfolios held Profound Medical Corp. (NASDAQ:PROF) at the end of the first quarter, compared to 10 in the previous quarter. While we acknowledge the potential of Profound Medical Corp. (NASDAQ:PROF) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In its first-quarter 2026 investor letter, Grow Funds highlighted Profound Medical Corp. (NASDAQ:PROF). Profound Medical Corp. (NASDAQ:PROF) is a Canada based commercial-stage medical device company that focuses on developing AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. On June 18, 2026, Profound Medical Corp. (NASDAQ:PROF) closed at $6.87 per share. One-month return of Profound Medical Corp. (NASDAQ:PROF) was 0.51%, and its shares gained 8.11% over the past 52 weeks. Profound Medical Corp. (NASDAQ:PROF) has a market capitalization of $248.09 million.
Grow Funds stated the following regarding Profound Medical Corp. (NASDAQ:PROF) in its Q1 2026 investor letter:
"Profound Medical Corp. (NASDAQ:PROF) is a commercial-stage medical device company advancing incision-free, MRI-guided, and robotically-driven technologies to treat prostate cancer and benign prostatic hyperplasia (BPH). Their lead technology, TULSA-PRO®, utilizes real-time MRI and thermal ultrasound to precisely ablate prostate tissue while preserving surrounding structures, aiming to minimize side effects like incontinence and impotence. Profound currently has 78 systems at marque hospitals, with a pipeline of over 110 systems. Reimbursement to the hospital is currently higher than competitive procedures. In addition, recent results from the Captain Trial demonstrate better outcomes than radical prostatectomy which is done primarily using the DaVinci robotic surgical system developed by Intuitive Surgical. Cook Medical and Siemens recently introduced their new iMRI suite, on which TULSA-PRO procedures can be performed."
Profound Medical Corp. (NASDAQ:PROF) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 6 hedge fund portfolios held Profound Medical Corp. (NASDAQ:PROF) at the end of the first quarter, compared to 10 in the previous quarter. While we acknowledge the potential of Profound Medical Corp. (NASDAQ:PROF) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
2 months ago
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Jeremy Renner was in a serious snowplow accident in 2023 that was near-fatal. And yet, the actor has since gone back to work on Mayor of Kingstown (which is expected to return on the 2026 TV schedule), done a movie and put out a memoir detailing his rehabilitation after the incident. He's made the bounce back from 38 broken bones and tissue damage look easy from the outside in, but in a new interview, he got honest about the fallout of the accident.
Back in January, Renner marked three years since the accident by joking about it, but it sounds like the experience continues to ricochet through his life and has given the 55-year-old a whole new perspective. In his words:
I mean, I'll be in recovery for the rest of my life. I think it goes beyond acting. I almost didn't want to go back into acting because I had to focus so much on real life. Nonfiction kind of stuff. To go into fiction was a little difficult, but I'm glad I'm back doing it.
Renner's recovery has been an extremely inspiring one. Just three months after he was run over by his seven-ton snowplow on his property in Nevada, he began to walk again – first with the ****** istance of an anti-gravity treadmill. A year after the event, he returned to work on Mayor of Kingstown and even did some of his own stunts on the crime thriller.
Jeremy Renner was in a serious snowplow accident in 2023 that was near-fatal. And yet, the actor has since gone back to work on Mayor of Kingstown (which is expected to return on the 2026 TV schedule), done a movie and put out a memoir detailing his rehabilitation after the incident. He's made the bounce back from 38 broken bones and tissue damage look easy from the outside in, but in a new interview, he got honest about the fallout of the accident.
Back in January, Renner marked three years since the accident by joking about it, but it sounds like the experience continues to ricochet through his life and has given the 55-year-old a whole new perspective. In his words:
I mean, I'll be in recovery for the rest of my life. I think it goes beyond acting. I almost didn't want to go back into acting because I had to focus so much on real life. Nonfiction kind of stuff. To go into fiction was a little difficult, but I'm glad I'm back doing it.
Renner's recovery has been an extremely inspiring one. Just three months after he was run over by his seven-ton snowplow on his property in Nevada, he began to walk again – first with the ****** istance of an anti-gravity treadmill. A year after the event, he returned to work on Mayor of Kingstown and even did some of his own stunts on the crime thriller.
